Bosh sahifaALPMY • OTCMKTS
add
Astellas Pharma ADR Representing 1 Ord Shs
Yopilish kursi
10,13 $
Kunlik diapazon
9,73 $ - 10,11 $
Yillik diapazon
9,15 $ - 13,14 $
Bozor kapitalizatsiyasi
2,83 trln JPY
Oʻrtacha hajm
138,26 ming
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (JPY) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 462,50 mlrd | 17,94% |
Joriy xarajat | 341,78 mlrd | 7,88% |
Sof foyda | 35,91 mlrd | 1 239,35% |
Sof foyda marjasi | 7,76 | 1 041,18% |
Har bir ulushga tushum | — | — |
EBITDA | 88,05 mlrd | 120,73% |
Amaldagi soliq stavkasi | 6,85% | — |
Balans
Jami aktivlari
Jami passivlari
| (JPY) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 292,99 mlrd | -12,28% |
Jami aktivlari | 3,46 trln | -2,28% |
Jami passivlari | 1,93 trln | 1,51% |
Umumiy kapital | 1,53 trln | — |
Tarqatilgan aksiyalar | 1,79 mlrd | — |
Narxi/balansdagi bahosi | 0,01 | — |
Aktivlardan daromad | 2,64% | — |
Kapitaldan daromad | 3,70% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (JPY) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 35,91 mlrd | 1 239,35% |
Operatsiyalardan naqd pul | 64,81 mlrd | 75,72% |
Sarmoyadan naqd pul | -16,38 mlrd | 97,88% |
Moliyadan naqd pul | -54,34 mlrd | -110,76% |
Naqd pulning sof oʻzgarishi | -9,94 mlrd | 95,63% |
Boʻsh pul | 43,59 mlrd | -17,69% |
Haqida
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Tashkil etilgan
1-apr, 2005
Bosh ofis
Sayt
Xodimlar soni
14 754
